Obesity drugmakers Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) have found themselves in two contrasting positions as Robert F. Kennedy Jr., a leading critic of weight loss drugs, takes the helm of the ...
These funds could be great long term picks for Aussie investors. The post Why these ASX ETFs could be top buy and hold ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback